Skip to main content

Articles

Page 5 of 16

  1. Opioid misuse screening in hospitals is resource-intensive and rarely done. Many hospitalized patients are never offered opioid treatment. An automated approach leveraging routinely captured electronic health ...

    Authors: Majid Afshar, Brihat Sharma, Sameer Bhalla, Hale M. Thompson, Dmitriy Dligach, Randy A. Boley, Ekta Kishen, Alan Simmons, Kathryn Perticone and Niranjan S. Karnik
    Citation: Addiction Science & Clinical Practice 2021 16:19
    Content type: Research Published on:

  2. Studies indicate high rates of substance use among youth experiencing homelessness (YEH). Further, the social networks of YEH, although multi-dimensional in composition, are largely comprised of other YEH, sub...

    Authors: Joan S. Tucker, David P. Kennedy, Karen Chan Osilla and Daniela Golinelli
    Citation: Addiction Science & Clinical Practice 2021 16:18
    Content type: Study Protocol Published on:

  3. Randomized trials of complex interventions are increasingly including qualitative components to further understand factors that contribute to their success. In this paper, we explore the experiences of health ...

    Authors: Nadia Minian, Aliya Noormohamed, Mathangee Lingam, Laurie Zawertailo, Bernard Le Foll, Jürgen Rehm, Norman Giesbrecht, Andriy V. Samokhvalov, Dolly Baliunas and Peter Selby
    Citation: Addiction Science & Clinical Practice 2021 16:17
    Content type: Research Published on:

  4. For many reasons, the emergency department (ED) is a critical venue to initiate OUD interventions. The prevailing culture of the ED has been that substance use disorders are non-emergent conditions better addr...

    Authors: Ryan P. McCormack, John Rotrosen, Phoebe Gauthier, Gail D’Onofrio, David A. Fiellin, Lisa A. Marsch, Patricia Novo, David Liu, E. Jennifer Edelman, Sarah Farkas, Abigail G. Matthews, Caroline Mulatya, Dagmar Salazar, Jeremy Wolff, Randolph Knight, William Goodman…
    Citation: Addiction Science & Clinical Practice 2021 16:16
    Content type: Study Protocol Published on:

  5. Opioid use disorder continues to be a significant problem in the United States and worldwide. Three medications—methadone, buprenorphine, and extended-release injectable naltrexone,— are efficacious for treati...

    Authors: Matisyahu Shulman, Roger Weiss, John Rotrosen, Patricia Novo, Elizabeth Costello and Edward V. Nunes
    Citation: Addiction Science & Clinical Practice 2021 16:15
    Content type: Review Published on:

  7. We describe addiction consult services (ACS) adaptations implemented during the Novel Coronavirus Disease 2019 (COVID-19) pandemic across four different North American sites: St. Paul’s Hospital in Vancouver, ...

    Authors: Miriam T. H. Harris, Alyssa Peterkin, Paxton Bach, Honora Englander, Emily Lapidus, Theresa Rolley, Melissa B. Weimer and Zoe M. Weinstein
    Citation: Addiction Science & Clinical Practice 2021 16:13
    Content type: Commentary Published on:

    The Correction to this article has been published in Addiction Science & Clinical Practice 2021 16:25

  8. The treatment capacity for opioid use disorder (OUD) lags far behind the number of patients in need of treatment. Capacity is limited, in part, by the limited number of physicians who offer office based OUD tr...

    Authors: Adriane M. dela Cruz, Robrina Walker, Ronny Pipes, Sidarth Wakhlu and Madhukar H. Trivedi
    Citation: Addiction Science & Clinical Practice 2021 16:12
    Content type: Research Published on:

  9. Buprenorphine/naloxone (Suboxone) is a current first-line treatment for opioid use disorder (OUD). The standard induction method of buprenorphine/naloxone requires patients to be abstinent from opioids and the...

    Authors: James S. H. Wong, Mohammadali Nikoo, Jean N. Westenberg, Janet G. Suen, Jennifer Y. C. Wong, Reinhard M. Krausz, Christian G. Schütz, Marc Vogel, Jesse A. Sidhu, Jessica Moe, Shane Arishenkoff, Donald Griesdale, Nickie Mathew and Pouya Azar
    Citation: Addiction Science & Clinical Practice 2021 16:11
    Content type: Study Protocol Published on:

  10. Recently, electronic cigarette (e-cig) usage has increased significantly, making it a potentially effective smoking cessation tool. In Muslim countries, most people who use e-cigarettes fast the month of Ramad...

    Authors: Muna M. Barakat, Raja’a A. Al-Qudah, Ibrahim Alfayoumi, Hala Jehad Al-Obaidi, Feras Jassim Jirjees and Iman Basheti
    Citation: Addiction Science & Clinical Practice 2021 16:10
    Content type: Research Published on:

  11. Most people with opioid use disorder (OUD) never receive treatment. Medication treatment of OUD in primary care is recommended as an approach to increase access to care. The PRimary Care Opioid Use Disorders t...

    Authors: Cynthia I. Campbell, Andrew J. Saxon, Denise M. Boudreau, Paige D. Wartko, Jennifer F. Bobb, Amy K. Lee, Abigail G. Matthews, Jennifer McCormack, David S. Liu, Megan Addis, Andrea Altschuler, Jeffrey H. Samet, Colleen T. LaBelle, Julia Arnsten, Ryan M. Caldeiro, Douglas T. Borst…
    Citation: Addiction Science & Clinical Practice 2021 16:9
    Content type: Study Protocol Published on:

  12. Increasingly, treatment for opioid use disorder (OUD) is offered in integrated treatment models addressing both substance use and other health conditions within the same system. This often includes offering me...

    Authors: Elizabeth C. Saunders, Sarah K. Moore, Olivia Walsh, Stephen A. Metcalf, Alan J. Budney, Patricia Cavazos-Rehg, Emily Scherer and Lisa A. Marsch
    Citation: Addiction Science & Clinical Practice 2021 16:8
    Content type: Research Published on:

  14. Opioid use disorder (OUD) is a medical condition that has evolved into a serious and deadly epidemic in the United States. Both medical and psychological interventions are called for to end this growing epidem...

    Authors: Hunter M. Puckett, Jenny S. Bossaller and Lincoln R. Sheets
    Citation: Addiction Science & Clinical Practice 2021 16:6
    Content type: Review Published on:

  15. The pandemic caused by Sars-CoV-2 (COVID-19) has been a great concern for public and mental health systems worldwide. The identification of risk groups is essential for the establishment of preventive and ther...

    Authors: Ellen Mello Borgonhi, Vanessa Loss Volpatto, Felipe Ornell, Francisco Diego Rabelo-da-Ponte and Felix Henrique Paim Kessler
    Citation: Addiction Science & Clinical Practice 2021 16:5
    Content type: Commentary Published on:

  16. The COVID-19 pandemic has resulted in unparalleled societal disruption with wide ranging effects on individual liberties, the economy, and physical and mental health. While no social strata or population has b...

    Authors: Ethan Cowan, Maria R. Khan, Siri Shastry and E. Jennifer Edelman
    Citation: Addiction Science & Clinical Practice 2021 16:4
    Content type: Commentary Published on:

  17. Effective brief treatments for methamphetamine use disorders (MAUD) are urgently needed to complement longer more intensive treatments in low and middle income countries, including South Africa. To address thi...

    Authors: K. Sorsdahl, D. J. Stein, S. Pasche, Y. Jacobs, R. Kader, B. Odlaug, S. Richter, B. Myers and J. E. Grant
    Citation: Addiction Science & Clinical Practice 2021 16:3
    Content type: Research Published on:

  18. Mutual support groups are a popular treatment for substance use and other addictive behaviours. However, little is known about the cultural utility of these programmes for Indigenous peoples.

    Authors: Elizabeth Dale, Katherine M. Conigrave, Peter J. Kelly, Rowena Ivers, Kathleen Clapham and K. S. Kylie Lee
    Citation: Addiction Science & Clinical Practice 2021 16:2
    Content type: Research Published on:

  19. Describe methods to compile a unified database from disparate state agency datasets linking person-level data on controlled substance prescribing, overdose, and treatment for opioid use disorder in Connecticut.

    Authors: William C. Becker, Robert Heimer, Catherine M. Dormitzer, Molly Doernberg, Gail D’Onofrio, Lauretta E. Grau, Kathryn Hawk, Hsiu-Ju Lin, Alex M. Secora and David A. Fiellin
    Citation: Addiction Science & Clinical Practice 2021 16:1
    Content type: Methodology Published on:

  22. Opioid use disorder (OUD) among women delivering at a hospital has increased 400% from 1999–2014 in the United States. From the years 2007 to 2016, opioid-related mortality during pregnancy increased over 200%...

    Authors: M. Aryana Bryan, Marcela C. Smid, Melissa Cheng, Katherine T. Fortenberry, Amy Kenney, Bhanu Muniyappa, Danielle Pendergrass, Adam J. Gordon and Gerald Cochran
    Citation: Addiction Science & Clinical Practice 2020 15:33
    Content type: Study Protocol Published on:

  23. Alcohol affects Indigenous communities globally that have been colonised. These effects are physical, psychological, financial and cultural. This systematic review aims to describe the prevalence of current (1...

    Authors: Teagan J. Weatherall, Katherine M. Conigrave, James H. Conigrave and K. S. Kylie Lee
    Citation: Addiction Science & Clinical Practice 2020 15:32
    Content type: Review Published on:

  24. First Nations peoples of Australia, New Zealand, the United States of America (USA) and Canada are more likely to be non-drinkers than other people in these countries. However, those who do drink may be at gre...

    Authors: Gemma C. Purcell-Khodr, K. S. Kylie Lee, James H. Conigrave, Emma Webster and Katherine M. Conigrave
    Citation: Addiction Science & Clinical Practice 2020 15:31
    Content type: Review Published on:

  25. Office-based buprenorphine treatment of opioid use disorder (OUD) does not typically include in-person directly observed therapy (DOT), potentially leading to non-adherence. Video DOT technologies may safeguar...

    Authors: Zachery A. Schramm, Brian G. Leroux, Andrea C. Radick, Alicia S. Ventura, Jared W. Klein, Jeffrey H. Samet, Andrew J. Saxon, Theresa W. Kim and Judith I. Tsui
    Citation: Addiction Science & Clinical Practice 2020 15:30
    Content type: Study Protocol Published on:

  26. Integrating behavioral health in primary care is a widespread endeavor. Yet rampant variation exists in models and approaches. One significant question is whether frontline providers perceive that behavioral h...

    Authors: Ida Q. Chen, Helene Chokron Garneau, Timothy Seay-Morrison, Megan R. Mahoney, Heather Filipowicz and Mark P. McGovern
    Citation: Addiction Science & Clinical Practice 2020 15:29
    Content type: Research Published on:

  27. At-risk levels of alcohol use threaten the health of patients with HIV (PWH), yet evidence-based strategies to decrease alcohol use and improve HIV-related outcomes in this population are lacking. We examined ...

    Authors: E. Jennifer Edelman, Stephen A. Maisto, Nathan B. Hansen, Christopher J. Cutter, James Dziura, Yanhong Deng, Lynn E. Fiellin, Patrick G. O’Connor, Roger Bedimo, Cynthia L. Gibert, Vincent C. Marconi, David Rimland, Maria C. Rodriguez-Barradas, Michael S. Simberkoff, Janet P. Tate, Amy C. Justice…
    Citation: Addiction Science & Clinical Practice 2020 15:28
    Content type: Research Published on:

  28. Aboriginal alcohol and other drug residential rehabilitation (residential rehabilitation) services have been providing treatment in Australia of over 50 years. However, there are no studies in Australia or int...

    Authors: Douglas B. James, KS Kylie Lee, Tania Patrao, Ryan J. Courtney, Katherine M. Conigrave and Anthony Shakeshaft
    Citation: Addiction Science & Clinical Practice 2020 15:27
    Content type: Research Published on:

  29. Young people experiencing homelessness have alarmingly high rates of alcohol and other drug (AOD) use, which is associated with sexual risk behaviors such as unprotected sex, trading sex, and sex with multiple...

    Authors: Joan S. Tucker, Elizabeth J. D’Amico, Eric R. Pedersen, Anthony Rodriguez and Rick Garvey
    Citation: Addiction Science & Clinical Practice 2020 15:26
    Content type: Study Protocol Published on:

  30. Opioid use disorders (OUDs) have devastating effects on individuals, families, and communities. While medication treatments for OUD save lives and are increasingly utilized, rates of treatment dropout are very...

    Authors: Karen Chan Osilla, Kirsten Becker, Liisa Ecola, Brian Hurley, Jennifer K. Manuel, Allison Ober, Susan M. Paddock and Katherine E. Watkins
    Citation: Addiction Science & Clinical Practice 2020 15:25
    Content type: Study Protocol Published on:

  31. Gaps in electronic health record (EHR) data collection and the paucity of standardized clinical data elements (CDEs) captured from electronic and digital data sources have impeded research efforts aimed at und...

    Authors: Arjun Venkatesh, Caitlin Malicki, Kathryn Hawk, Gail D’Onofrio, Jeremiah Kinsman and Andrew Taylor
    Citation: Addiction Science & Clinical Practice 2020 15:24
    Content type: Research Published on:

  32. A lack of culturally and linguistically appropriate smoking cessation intervention programs exist among Chinese-Canadian communities. Smoking cessation programs that are provided in Canadian mainstream culture...

    Authors: Iraj Poureslami, Jessica Shum, Niloufar Aran and Noah Tregobov
    Citation: Addiction Science & Clinical Practice 2020 15:23
    Content type: Research Published on:

  33. Internet-based treatment has emerged as a cost-effective option for reaching people who for different reasons are not reached by traditional treatment. Internet-based treatment for problematic alcohol use, spe...

    Authors: Veronica Ekström and Magnus Johansson
    Citation: Addiction Science & Clinical Practice 2020 15:22
    Content type: Research Published on:

  34. In response to the findings of the Lynch et al. study on the association of suicide mortality and substance use disorder, this commentary addresses the need for increased suicide assessment and screening for p...

    Authors: Virna Little and Mary Crawford James
    Citation: Addiction Science & Clinical Practice 2020 15:21
    Content type: Commentary Published on:

  35. The process by which state Medicaid programs develop their preferred drug lists, and determine which medications require prior authorization, is opaque to many clinicians. This process is a synthesis of cost a...

    Authors: Marcus A. Bachhuber
    Citation: Addiction Science & Clinical Practice 2020 15:20
    Content type: Review Published on:

  36. There is growing public health concern around the potential impact of the opioid crisis on efforts to eradicate HIV. This secondary analysis seeks to determine if those who report opioids as their primary prob...

    Authors: Lacey Critchley, Adam Carrico, Natalie Gukasyan, Petra Jacobs, Raul N. Mandler, Allan E. Rodriguez, Carlos del Rio, Lisa R. Metsch and Daniel J. Feaster
    Citation: Addiction Science & Clinical Practice 2020 15:19
    Content type: Research Published on:

  37. For persons with substance use disorders (SUDs), 12-step groups (TSGs) are the most available and used peer-based recovery resource, worldwide. However, disengagement is common, and attrition may partly be due...

    Authors: John-Kåre Vederhus, Magnhild Høie and Bente Birkeland
    Citation: Addiction Science & Clinical Practice 2020 15:18
    Content type: Research Published on:

  38. Smartphone applications (apps) designed to assist users to reduce hazardous and harmful alcohol consumption show potential as an inexpensive alternative to traditional brief intervention in primary care. The a...

    Authors: Stephanie Colbert, Louise Thornton and Robyn Richmond
    Citation: Addiction Science & Clinical Practice 2020 15:17
    Content type: Review Published on:

  39. Buprenorphine-naloxone is an evidence-based treatment for Opioid Use Disorder. However, despite its efficacy, nearly half of participants are unsuccessful in achieving stabilization (i.e., period of time follo...

    Authors: Kirsten J. Langdon, Susan Ramsey, Caroline Scherzer, Kate Carey, Megan L. Ranney and Josiah Rich
    Citation: Addiction Science & Clinical Practice 2020 15:16
    Content type: Study Protocol Published on:

  40. Persons with an opioid use disorder (OUD) who were incarcerated face many challenges to remaining abstinent; concomitantly, opioid-overdose is the leading cause of death among this population, with the initial...

    Authors: Sean M. Murphy, Philip J. Jeng, Sabrina A. Poole, Ali Jalali, Frank J. Vocci, Michael S. Gordon, George E. Woody and Daniel Polsky
    Citation: Addiction Science & Clinical Practice 2020 15:15
    Content type: Study Protocol Published on:

  41. Prior research suggests that substance use disorders (SUDs) are associated with risk of suicide mortality, but most previous work has been conducted among Veterans Health Administration patients. Few studies h...

    Authors: Frances L. Lynch, Edward L. Peterson, Christine Y. Lu, Yong Hu, Rebecca C. Rossom, Beth E. Waitzfelder, Ashli A. Owen-Smith, Samuel Hubley, Deepak Prabhakar, L. Keoki Williams, Arne Beck, Gregory E. Simon and Brian K. Ahmedani
    Citation: Addiction Science & Clinical Practice 2020 15:14
    Content type: Research Published on:

  42. Emerging data points to a potential heroin use epidemic in South Africa. Despite this, access to methadone maintenance therapy and other evidence-based treatment options remains negligible. We aimed to assess ...

    Authors: Andrew Scheibe, Shaun Shelly, Tara Gerardy, Zara von Homeyer, Andrea Schneider, Kalvanya Padayachee, Shalon Balaguru Naidoo, Klaas Mtshweni, Ayanda Matau, Harry Hausler and Monique Marks
    Citation: Addiction Science & Clinical Practice 2020 15:13
    Content type: Research Published on:

  43. Cigarette smoking is much more prevalent among young people experiencing homelessness than in the general population of adolescents and young adults. Although many young homeless smokers are motivated to quit,...

    Authors: Joan S. Tucker, Eric R. Pedersen, Sebastian Linnemayr, William G. Shadel, Maria DeYoreo and Rushil Zutshi
    Citation: Addiction Science & Clinical Practice 2020 15:11
    Content type: Study Protocol Published on:

  44. The aim of this study was to investigate the effects of a web-based treatment program with therapist guidance for adults and adolescents with regular cannabis use from the general population.

    Authors: Kristina Sinadinovic, Magnus Johansson, Ann-Sofie Johansson, Thomas Lundqvist, Philip Lindner and Ulric Hermansson
    Citation: Addiction Science & Clinical Practice 2020 15:9
    Content type: Research Published on:

  45. This special issue of Addiction Science & Clinical Practice, “Addiction treatment access and utilization among criminal justice involved populations”, presents a series of articles on substance use disorder tr...

    Authors: Andrea Finlay, Ingrid Binswanger and Christine Timko
    Citation: Addiction Science & Clinical Practice 2020 15:5
    Content type: Editorial Published on:

  46. Treatment completion is the greatest challenge for the treatment of substance use disorders (SUDs). A previous investigation showed that complementary horse-assisted therapy (cHAT) was associated with higher r...

    Authors: Francesca Gatti, Espen Walderhaug, Ann Kern-Godal, Jeanette Lysell and Espen Ajo Arnevik
    Citation: Addiction Science & Clinical Practice 2020 15:7
    Content type: Research Published on:

  47. Hookah smoking is an emerging global health issue, especially in Eastern Mediterranean region; and accordingly, women are at the center of this issue as they have a more positive attitude towards hookah smokin...

    Authors: Sakineh Dadipoor, Gerjo Kok, Ali Heyrani, Teamur Aghamolaei, Mohtasham Ghaffari and Amin Ghanbarnezhad
    Citation: Addiction Science & Clinical Practice 2020 15:6
    Content type: Study Protocol Published on:

  48. There is an urgent need for strategies to address the US epidemic of prescription opioid, heroin and fentanyl-related overdoses, misuse, addiction, and diversion. Evidence-based treatment such as medications f...

    Authors: Gavin B. Bart, Andrew Saxon, David A. Fiellin, Jennifer McNeely, John P. Muench, Christopher W. Shanahan, Kristen Huntley and Robert E. Gore-Langton
    Citation: Addiction Science & Clinical Practice 2020 15:4
    Content type: Meeting Report Published on:

  49. Urine drug monitoring for medications for opioid use disorder (MOUD) such as buprenorphine can help to support treatment adherence. The practice of introducing unconsumed medication directly into urine (known ...

    Authors: Jill S. Warrington, Kaitlyn Booth, Gregory S. Warrington and Samuel Francis-Fath
    Citation: Addiction Science & Clinical Practice 2020 15:3
    Content type: Case Study Published on:
Submit manuscript

Follow

Affiliated with

Annual Journal Metrics

  • 2022 Citation Impact
    3.7 - 2-year Impact Factor
    4.4 - 5-year Impact Factor
    0.956 - SNIP (Source Normalized Impact per Paper)
    1.166 - SJR (SCImago Journal Rank)

    2022 Speed
    17 days submission to first editorial decision for all manuscripts (Median)
    193 days submission to accept (Median)

    2022 Usage 
    679,436 downloads
    1,570 Altmetric mentions 

Archival content

Addiction Science & Clinical Practice was formerly published by NIDA and previous issues of the journal can be viewed here.

Addiction Science & Clinical Practice

ISSN: 1940-0640